|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 127.34 USD | -1.91% |
|
-2.14% | +24.67% |
| 13/06 | Guardant Health Set to Benefit From Genomic Profiling Growth, RBC Says | MT |
| 12/06 | RBC Initiates Guardant Health at Outperform With $185 Price Target | MT |
| Market Cap | 16.89B 14.55B 13.4B 12.58B 23.62B 1,596B 23.87B 158B 61.69B 782B 63.37B 62.02B 2,709B | P/E Ratio 2026 * |
-43.9x | P/E Ratio 2027 * | -61.1x |
|---|---|---|---|---|---|
| Enterprise Value | 17.4B 14.99B 13.81B 12.96B 24.34B 1,645B 24.59B 163B 63.56B 805B 65.29B 63.9B 2,791B | EV / Sales 2026 * |
13.2x | EV / Sales 2027 * | 10.2x |
| Free-Float |
95.75% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Guardant Health, Inc.
| 1 day | -1.91% | ||
| 1 week | -2.14% | ||
| Current month | -1.81% | ||
| 1 month | +34.16% | ||
| 3 months | +46.07% | ||
| 6 months | +27.34% | ||
| Current year | +24.67% |
| 1 week | 126.76 |  | 135 |
| 1 month | 93.29 | | 135 |
| Current year | 74.55 | | 135 |
| 1 year | 40.36 | | 135 |
| 3 years | 15.81 | | 135 |
| 5 years | 15.81 | | 135 |
| 10 years | 15.81 | | 181.07 |
| Manager | Title | Age | Since |
|---|---|---|---|
AmirAli Talasaz
CEO | Chief Executive Officer | 46 | 05/08/2021 |
Helmy Eltoukhy
CEO | Chief Executive Officer | 47 | 01/01/2013 |
Michael Bell
DFI | Director of Finance/CFO | 57 | 05/01/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Helmy Eltoukhy
CHM | Chairman | 47 | 05/08/2021 |
AmirAli Talasaz
CHM | Chairman | 46 | 01/01/2013 |
Ian Clark
BRD | Director/Board Member | 65 | 01/12/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11/06 | Sell | Chief Technology Officer | -3,418 | 0.0026% | ||
| 10/06 | Sell | Chief Technology Officer | -5,000 | 0.0038% | ||
| 05/06 | Sell | Chief Executive Officer | -100,000 | 0.0754% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.91% | -2.14% | +158.30% | +243.33% | 16.89B | |
| -0.44% | -3.42% | -43.31% | -25.01% | 9.32B | |
| +0.34% | +5.05% | +34.97% | +18.99% | 6.84B | |
| -1.10% | +6.01% | - | - | 5.08B | |
| -1.12% | -0.53% | -25.82% | -30.27% | 5.02B | |
| +5.84% | +4.73% | +96.62% | +93.29% | 4.39B | |
| -2.44% | -7.48% | -30.61% | -34.48% | 4.09B | |
| -1.46% | +3.79% | +188.37% | -45.36% | 4.03B | |
| -1.87% | +5.99% | -15.51% | -41.95% | 2.66B | |
| +9.45% | +1.37% | -2.08% | -26.02% | 1.42B | |
| Average | +0.52% | +2.58% | +40.10% | +16.95% | 5.97B | |
| Weighted average by Cap. | -0.46% | +0.84% | +62.08% | +69.35% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.31B 1.13B 1.04B 979M 1.84B 124B 1.86B 12.32B 4.8B 60.85B 4.93B 4.83B 211B | 1.7B 1.47B 1.35B 1.27B 2.38B 161B 2.4B 15.94B 6.21B 78.71B 6.38B 6.24B 273B |
| Net income | -380M -327M -301M -283M -531M -35.92B -537M -3.56B -1.39B -17.59B -1.43B -1.4B -60.95B | -257M -221M -204M -191M -359M -24.27B -363M -2.41B -938M -11.88B -963M -943M -41.18B |
| Net Debt | 512M 441M 406M 381M 716M 48.4B 724M 4.8B 1.87B 23.7B 1.92B 1.88B 82.14B | 445M 383M 353M 331M 622M 42.05B 629M 4.17B 1.62B 20.59B 1.67B 1.63B 71.36B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/06/26 | 127.34 $ | -1.91% | 2,672,704 |
| 15/06/26 | 129.82 $ | -1.37% | 1,649,050 |
| 12/06/26 | 131.62 $ | +0.55% | 1,511,450 |
| 11/06/26 | 130.90 $ | +0.15% | 1,502,610 |
| 10/06/26 | 130.70 $ | +0.45% | 1,797,499 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GH Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition